Stop Your Clinical Manuscript from Being Rejected with Better IMRaD Structure
Most researchers know IMRaD stands for Introduction, Methods, Results, and Discussion. Very few know what those sections are actually supposed to do. Even fewer realize that writing them in the order they appear in the final paper is a huge mistake. This habit leads to structural errors that get papers rejected before a reviewer even looks at the science.
If you write your introduction first, you’re writing blind. You don’t know which gaps in the literature matter because you haven’t focused on your findings yet. This makes your background irrelevant and your objectives vague. To fix this, you need to separate the reading order from the writing order.
Each part of your paper has one job. If a section tries to answer two questions, it loses focus. When you keep these roles distinct, your paper becomes a clear argument rather than a data dump.
The Introduction establishes the why
The introduction answers one question: Why did this research need to happen? You start by stating the problem in the current literature. You then identify the specific gap your study fills. The section should end with your study objective.
Do not fill this space with general background for the sake of it. If the information doesn’t lead directly to your objective, cut it.
The Methods explain the how
This section answers how exactly the work was done. The goal is simple: someone else should be able to replicate your study using only this text.
You must include:
The study design in the first sentence.
The population, including who you kept in and who you left out.
The primary outcome measure and how you quantified it.
Your statistical approach.
The Results report the what
The results section answers what was found. It should contain raw data and specific numbers without any interpretation. You must report primary outcomes, secondary outcomes, and any unexpected or adverse findings.
Never hide data that didn’t fit your hypothesis. Reviewers spot omissions quickly, and it hurts your credibility.
The Discussion explains the so what
This is where you answer what the findings mean and what should change in the real world. It’s the most complex part of the paper and requires a specific four-part flow.
A plain language summary of the primary finding.
A comparison to existing literature with specific citations.
Practical or clinical implications for practitioners.
A clear list of limitations and how they affect your conclusions.
Reverse the Writing Order for Better Clinical Manuscript Structure
Writing a paper from start to finish is a trap. It feels logical, but it’s backwards. To maintain structural integrity, you should write your sections in a strategic sequence.
Start with the Results. Write exactly what you found first. This anchors your entire paper in fact. Once the data is on the page, move to the Methods. Now you can explain how you got those specific results without forgetting any steps.
Next, write the Introduction. Since you now know your results, you can pick the background information that actually matters. You can frame the gap in the literature to lead perfectly into your findings.
Finish with the Discussion. Use the results to build your summary and your literature review to build your comparison. Let the data dictate the implications, not your hopes for the study.
Common Structural Errors That Trigger Rejection
Many papers fail structural review because authors mix the roles of different sections. The most frequent mistake is putting interpretation in the results.
For example, a writer might say, “Female donors showed lower ferritin levels, suggesting that sex-stratified intervals are needed.” The second half of that sentence is an interpretation. It does not belong in the results. It belongs in the discussion.
A clean results section would simply state, “Female donors showed lower ferritin levels.” If you see words like “suggests,” “indicates,” or “demonstrates that” in your results, move those sentences to the discussion.
Another common error is introducing new results in the discussion. The discussion is for interpreting data you already presented. If you find yourself describing a new table or a new p-value in the discussion, you’ve missed a spot in your results section.
Improving Your Methods for Better Replication
Authors often write the methods section too briefly. They assume the reviewer shares their context. Reviewers don’t. They reject papers because there isn’t enough detail to repeat the experiment.
Take the study “Assessment of iron profile and hematological parameters among regular blood donors at NBTS, Owerri.” This paper succeeds because it’s specific. It starts with the design: a cross-sectional study of 150 regular donors.
It doesn’t just say “donors.” It lists inclusion criteria, like having three or more donations. It lists exclusion criteria, like iron supplementation within three months. It defines the primary outcome as serum ferritin concentration measured by ELISA. That level of detail prevents rejection.
Defining Actionable Clinical Implications
Many researchers end their discussion with a vague sentence like “further research is needed.” This is a red flag for reviewers. It’s an admission that you haven’t thought about what your data actually supports.
Instead, provide a specific recommendation. If your data shows a certain group is at higher risk, suggest a change in screening intervals or a new diagnostic protocol. Tell the reader exactly what a doctor or policy maker should do differently tomorrow because of your study.
Final Thoughts on the IMRaD Framework
A strong clinical manuscript isn’t about the amount of data you have. It’s about how you organize that data. When you treat IMRaD as four distinct questions rather than four random sections, your writing becomes sharper.
Remember to write your results first and your discussion last. Keep your data in the results and your opinions in the discussion. Be overly detailed in your methods so no one has to guess how you did the work.
If you follow this structure, you stop fighting with your draft and start building a credible case for your research. This approach moves your work past the structural review and puts it in front of the people who can actually evaluate your science.
By administrator
